View Exam | PowerPak

1. Which of the following is NOT a social determinant of health:

A. Health Care Access and Quality B. Chronic Health Conditions C. Community and Social Context D. Neighborhood and Physical Environment E. Unsure

2. Which of the following is more likely to be linked to drug overdose death rates in rural regions as compared to urban regions?

A. Tramadol B. Fentanyl C. Methadone D. Oxycodone E. Unsure

3. A 32-year-old White male living in rural West Virginia presents to your clinic for the first time with complaints of knee pain. The patient has a history of knee arthroplasty that was done 2 years ago, and the patient states his pain was managed by his orthopedist with oxycodone, and that is the only thing that is helping ease his pain. The patient's past medical history includes diagnoses of depression, type 1 diabetes, and seasonal allergies. Reviewing his medical chart, you see his pain is currently being managed with prescription strength ibuprofen from that same orthopedist. Which risk factor(s) does this patient have that correlate with high-risk opioid use?

A. Age B. History of chronic pain C. History of mental health disorders D. All of the above E. Unsure

4. Which barrier(s) can be prevalent for rural patients when accessing care for the treatment of opioid use disorder (OUD)?

A. Lack of opioid specialty clinics B. Transportation and travel durations C. Lack of waivered buprenorphine practitioners D. All of the above E. Unsure

5. Stigma towards patients with OUD is more prevalent from the general population than healthcare providers?

A. True B. False C. Unsure

6. Which of the following is/are potential concerns voiced by patients that contribute to patient barriers to OUD treatment?

A. Perception that utilizing OUD treatment is replacing one addiction for another B. Perceived or actual side effects of OUD treatment C. Hearing negative opinions about OUD treatment from others D. All of the above E. Unsure

7. Which risk factor for OUD is highly prevalent in the veteran population?

A. Chronic pain B. Isolation C. Increased access to providers D. Tobacco use E. Unsure

8. Which of the following is NOT a patient-reported assessment tool for high-risk opioid use?

A. Current Opioid Misuse Measure (COMM) B. Opioid Risk Tool (ORT) C. Prescription drug monitoring program (PDMP) D. Screener and Opioid Assessment for Patients with Pain-Revised (SOAPP-R) E. Unsure

9. Which of the following is a provider-based strategy that addresses stigmatizing attitudes towards patients with high-risk opioid use?

A. Targeted education early on in training on high-risk opioid use (in graduate school and/or residency) B. Increased funding for loan repayment programs for addiction specialists who treat substance use disorders C. Improving care coordination by increasing data sharing for high-quality care (such as increased integration with prescription drug monitoring programs) D. Increased state and federal legislation for opioid prescription prescribing limitations and mandates to help identify fraudulent prescriptions E. Unsure

10. How can pharmacists encourage decreased opioid prescription sharing, theft, and overdose deaths?

A. Hosting drug take-back events or encouraging use of permanent medication disposal sites B. Identify individuals at high-risk for overdose and provide naloxone C. Educate and counsel patients on proper safe storage of their prescriptions D. All of the above E. Unsure

Maintenance is scheduled for 8/7/2023 7:00 AM EST - 8:00 AM EST.

{{recommendationsA.Title}}

{{recommendationsB.Title}}

1. Which of the following is NOT a social determinant of health:

2. Which of the following is more likely to be linked to drug overdose death rates in rural regions as compared to urban regions?

4. Which barrier(s) can be prevalent for rural patients when accessing care for the treatment of opioid use disorder (OUD)?

5. Stigma towards patients with OUD is more prevalent from the general population than healthcare providers?

6. Which of the following is/are potential concerns voiced by patients that contribute to patient barriers to OUD treatment?

7. Which risk factor for OUD is highly prevalent in the veteran population?

8. Which of the following is NOT a patient-reported assessment tool for high-risk opioid use?

9. Which of the following is a provider-based strategy that addresses stigmatizing attitudes towards patients with high-risk opioid use?

10. How can pharmacists encourage decreased opioid prescription sharing, theft, and overdose deaths?

« Return to Activity

Maintenance is scheduled for 8/7/2023 7:00 AM EST - 8:00 AM EST.

The shopping cart is empty

Customers who Purchasedthis Activity also Purchased

{{recommendationsA.Title}}

{{recommendationsB.Title}}

1. Which of the following is NOT a social determinant of health:

2. Which of the following is more likely to be linked to drug overdose death rates in rural regions as compared to urban regions?

4. Which barrier(s) can be prevalent for rural patients when accessing care for the treatment of opioid use disorder (OUD)?

5. Stigma towards patients with OUD is more prevalent from the general population than healthcare providers?

6. Which of the following is/are potential concerns voiced by patients that contribute to patient barriers to OUD treatment?

7. Which risk factor for OUD is highly prevalent in the veteran population?

8. Which of the following is NOT a patient-reported assessment tool for high-risk opioid use?

9. Which of the following is a provider-based strategy that addresses stigmatizing attitudes towards patients with high-risk opioid use?

10. How can pharmacists encourage decreased opioid prescription sharing, theft, and overdose deaths?

« Return to Activity

Customers who Purchased
this Activity also Purchased